» Articles » PMID: 37605707

The Clinical Caveat for Treating Persistent Hypokalemia in Diabetic Ketoacidosis

Overview
Journal Cureus
Date 2023 Aug 22
PMID 37605707
Authors
Affiliations
Soon will be listed here.
Abstract

The medical community seeks to provide evidence-based guidelines for treating any disease to ensure optimal care delivery. Occasionally, a patient's unique physiology does not respond to guideline-driven treatments and requires experienced clinical personalization for treatment. Failure of clinicians to recognize patient outliers and augment care can delay treatment, provide substandard care, and potentially threaten a patient's life. This paper describes a clinical caveat for treating profound or persistent hypokalemia in patients with DKA (diabetic ketoacidosis).

References
1.
Hursh B, Ronsley R, Islam N, Mammen C, Panagiotopoulos C . Acute Kidney Injury in Children With Type 1 Diabetes Hospitalized for Diabetic Ketoacidosis. JAMA Pediatr. 2017; 171(5):e170020. DOI: 10.1001/jamapediatrics.2017.0020. View

2.
Pasquel F, Tsegka K, Wang H, Cardona S, Galindo R, Fayfman M . Clinical Outcomes in Patients With Isolated or Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State: A Retrospective, Hospital-Based Cohort Study. Diabetes Care. 2019; 43(2):349-357. PMC: 6971788. DOI: 10.2337/dc19-1168. View

3.
Dhatariya K, Nunney I, Higgins K, Sampson M, Iceton G . National survey of the management of Diabetic Ketoacidosis (DKA) in the UK in 2014. Diabet Med. 2015; 33(2):252-60. DOI: 10.1111/dme.12875. View

4.
Palmer B, Clegg D . Electrolyte and Acid-Base Disturbances in Patients with Diabetes Mellitus. N Engl J Med. 2015; 373(6):548-59. DOI: 10.1056/NEJMra1503102. View

5.
Syed Z, Kimball T, Ismail M . Successful Use of Renal Replacement Therapy for Refractory Hypokalemia in a Diabetic Ketoacidosis Patient. Case Rep Crit Care. 2019; 2019:6130694. PMC: 6710747. DOI: 10.1155/2019/6130694. View